Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.

Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV; NHLBI Working Group..

Am J Med Genet A. 2006 May 15;140(10):1033-40.

2.

Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2010 Dec;12(12):839-43. doi: 10.1097/GIM.0b013e3181f872c0.

PMID:
21042222
3.

Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.

Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S.

J Am Coll Cardiol. 2015 Feb 24;65(7):738-44. doi: 10.1016/j.jacc.2014.12.014. Review.

4.

Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease.

Williams RG, Pearson GD, Barst RJ, Child JS, del Nido P, Gersony WM, Kuehl KS, Landzberg MJ, Myerson M, Neish SR, Sahn DJ, Verstappen A, Warnes CA, Webb CL; National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease..

J Am Coll Cardiol. 2006 Feb 21;47(4):701-7. Epub 2006 Jan 26.

6.

Disclosure of genetic information obtained through research.

Quaid KA, Jessup NM, Meslin EM.

Genet Test. 2004 Fall;8(3):347-55. Review.

PMID:
15727261
7.

Preparticipation cardiovascular screening.

Seto CK.

Clin Sports Med. 2003 Jan;22(1):23-35. Review.

PMID:
12613084
8.

Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.

Sharma P, Boyers D, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Kilonzo M, McNamee P, Mowatt G.

Health Technol Assess. 2012;16(17):1-266. doi: 10.3310/hta16170. Review.

9.

Future directions in sarcoidosis research: summary of an NHLBI working group.

Martin WJ 2nd, Iannuzzi MC, Gail DB, Peavy HH.

Am J Respir Crit Care Med. 2004 Sep 1;170(5):567-71. Epub 2004 May 13. Review.

PMID:
15142870
10.

Genetic testing, screening, and counseling issues in cardiovascular disease.

Lashley FR.

J Cardiovasc Nurs. 1999 Jul;13(4):110-26. Review.

PMID:
10386275
11.

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy..

Hypertension. 2003 Mar;41(3):437-45. Epub 2003 Feb 10. Review.

12.

Challenges and standards in reporting diagnostic and prognostic biomarker studies.

Azuaje F, Devaux Y, Wagner D.

Clin Transl Sci. 2009 Apr;2(2):156-61. doi: 10.1111/j.1752-8062.2008.00075.x. Review.

PMID:
20443882
13.

Genetic testing in cardiovascular diseases.

Hofman N, van Langen I, Wilde AA.

Curr Opin Cardiol. 2010 May;25(3):243-8. doi: 10.1097/HCO.0b013e3283374d69. Review.

PMID:
20164764
14.

The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia.

Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB.

CMAJ. 1999 Jun 15;160(12 Suppl):S1-15. Review.

15.

Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease.

Iadecola C, Goldman SS, Harder DR, Heistad DD, Katusic ZS, Moskowitz MA, Simard JM, Sloan MA, Traystman RJ, Velletri PA.

Stroke. 2006 Jun;37(6):1578-81. Epub 2006 Apr 20.

16.

Genetic testing in cardiovascular medicine: current landscape and future horizons.

Sturm AC, Hershberger RE.

Curr Opin Cardiol. 2013 May;28(3):317-25. doi: 10.1097/HCO.0b013e32835fb728. Review.

PMID:
23571470
17.

Incidental findings in genetic research and clinical diagnostic tests: a systematic review.

Jackson L, Goldsmith L, O'Connor A, Skirton H.

Am J Med Genet A. 2012 Dec;158A(12):3159-67. doi: 10.1002/ajmg.a.35615. Epub 2012 Nov 19. Review.

PMID:
23166054
18.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
19.

Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2014 Apr;16(4):338-46. doi: 10.1038/gim.2013.141. Epub 2013 Sep 26. Review.

PMID:
24071797
20.

Technical Update: Preimplantation Genetic Diagnosis and Screening.

Dahdouh EM, Balayla J, Audibert F; Genetics Committee., Wilson RD, Audibert F, Brock JA, Campagnolo C, Carroll J, Chong K, Gagnon A, Johnson JA, MacDonald W, Okun N, Pastuck M, Vallée-Pouliot K.

J Obstet Gynaecol Can. 2015 May;37(5):451-63. Review.

PMID:
26168107

Supplemental Content

Support Center